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ORIGINAL RESEARCH

Potential Consequences of the Red
Blood Cell Storage Lesion on Cardiac
Electrophysiology
Marissa Reilly, MS*; Chantal D. Bruno, DO*; Tomas M. Prudencio, MS; Nina Ciccarelli, BS; Devon Guerrelli, MS;
Raj Nair, BS; Manelle Ramadan, BS; Naomi L. C. Luban, MD; Nikki Gillum Posnack , PhD
BACKGROUND: The red blood cell (RBC) storage lesion is a series of morphological, functional, and metabolic changes that
RBCs undergo following collection, processing, and refrigerated storage for clinical use. Since the biochemical attributes of
the RBC unit shifts with time, transfusion of older blood products may contribute to cardiac complications, including hyperkalemia and cardiac arrest. We measured the direct effect of storage age on cardiac electrophysiology and compared it with
hyperkalemia, a prominent biomarker of storage lesion severity.
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METHODS AND RESULTS: Donor RBCs were processed using standard blood-banking techniques. The supernatant was collected from RBC units, 7 to 50 days after donor collection, for evaluation using Langendorff-heart preparations (rat) or human
induced pluripotent stem cell–derived cardiomyocytes. Cardiac parameters remained stable following exposure to “fresh”
supernatant from red blood cell units (day 7: 5.8±0.2 mM K+), but older blood products (day 40: 9.3±0.3 mM K+) caused
bradycardia (baseline: 279±5 versus day 40: 216±18 beats per minute), delayed sinus node recovery (baseline: 243±8 versus
day 40: 354±23 ms), and increased the effective refractory period of the atrioventricular node (baseline: 77±2 versus day
40: 93±7 ms) and ventricle (baseline: 50±3 versus day 40: 98±10 ms) in perfused hearts. Beating rate was also slowed in
human induced pluripotent stem cell–derived cardiomyocytes after exposure to older supernatant from red blood cell units
(−75±9%, day 40 versus control). Similar effects on automaticity and electrical conduction were observed with hyperkalemia
(10–12 mM K+).
CONCLUSIONS: This is the first study to demonstrate that “older” blood products directly impact cardiac electrophysiology,
using experimental models. These effects are likely caused by biochemical alterations in the supernatant from red blood cell
units that occur over time, including, but not limited to hyperkalemia. Patients receiving large volume and/or rapid transfusions
may be sensitive to these effects.
Key Words: cardiac electrophysiology ■ hyperkalemia ■ red blood cell storage lesion

M

ore than 13 million whole blood and red blood
cell (RBC) units are transfused in the United
States each year, with cardiac surgical procedures accounting for ≈20% of all blood transfusions.1–7
Many cardiac procedures mandate the use of blood
and blood products in the preoperative, intraoperative,
and postoperative period, particularly with infant and

pediatric patients for cardiopulmonary bypass circuitry
priming.3,8 Despite the frequency, transfusion of blood
and blood products is not without risk.9,10 Transfusion of
RBCs in particular has been associated with increased
morbidity and mortality, prolongation of hospital stay,
and several different cardiac complications.9–17 Many
investigators have suggested that RBC transfusion
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CLINICAL PERSPECTIVE
What Is New?

• This study is the first to demonstrate that
“older” red blood cell products (as compared
with “fresh” products) may directly impact myocardial automaticity and electrical conduction,
using experimental cardiac models.

What Are the Clinical Implications?

• Transfusion-induced hyperkalemic cardiac
arrest is a recognized complication of transfusions; our study suggests that cardiac complications could be linked to high potassium
concentrations in red blood cells units that are
close to expiration.

Nonstandard Abbreviations and Acronyms
AS-1 or AS-3
AVNERP
hiPSC-CM
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KH
MEA
RBC
SNRT
sRBC
VERP
WBCL

additive solution-1 or additive
solution-3
atrioventricular node effective
refractory period
human induced pluripotent stem
cell–derived cardiomyocytes
Krebs-Henseleit media
microelectrode array
red blood cell
sinus node recovery time
supernatant from red blood cell
units
ventricular effective refractory
period
Wenckebach cycle length

complications are caused by the transfusion of RBCs
close to their expiration (42 days), wherein the effects
of the RBC storage lesion can contribute to the pathobiology of adverse reactions.12,14,18–25 These pathobiological changes include clearance of storage-damaged
RBCs, aberration of nitric oxide metabolism, trapping
of RBCs by macrophages resulting in oxidative damage and impaired oxygen delivery, and an increase
in circulating nontransferrin bound iron.24,26–28 Briefly,
over time, stored RBCs are depleted of ATP, which alters the RBC cell membrane, resulting in hemolysis,
the formation of RBC microvesicles, release of intracellular iron, decreased nontransferrin bound iron, and the
release of free hemoglobin. Furthermore, the pH and
electrolyte composition of the RBC unit also changes
because of continued anaerobic metabolism and dysfunction of cation transporters. The latter includes

impairment of Na+/K+ ATPase,29 which leads to a progressive increase of extracellular [K+] in the RBC unit
supernatant.30,31 Consequently, rapid or large-volume
transfusions of RBC units with elevated potassium
levels can predispose patients to hyperkalemia, conduction abnormalities, and cardiac arrest.14,15,18,19,22,32
Although the incidence of transfusion-associated hyperkalemia is poorly defined and potentially underreported,14 Raza et al. noted elevated K+ levels in >70%
of adult trauma patients following transfusion,18 and
Livingston et al. observed hyperkalemia in 18% to 23%
of pediatric trauma patients following transfusion.33
Transfusion-associated hyperkalemia resulting in cardiac arrest is a recognized complication of massive
transfusion in children, with a mean serum [K+] level
of 9.2±1.8 mM in patients who experienced cardiac arrest.14 Some investigators suggest that the risk factors
for transfusion-associated hyperkalemia resulting in
cardiac arrest include the volume and rate of transfusion, storage age, and irradiation of RBCs, but the perceived risk and reason for such cardiac complications
remain actively debated.14,31,34,35
Chronological storage age is one of the key factors that influence RBC quality and storage lesion
severity.29,30,36 Despite this, blood banks often employ a “first-in, first-out” approach to reduce blood
product waste and maintain an inventory supply to
support emergency transfusions. Indeed, it is estimated that 10% to 20% of RBC units are transfused
after 35 days of refrigerated storage, or near their
42-day expiration date.37 Some investigators have
recommended a reduction in the maximum allowable storage time for RBCs because of quality concerns.18,24,27,38–41 Several clinical studies have raised
concerns about the effects of the RBC storage lesion14,15,20,22,23,42,43; however, the direct impact of
RBC quality on cardiac health outcomes remains unclear. Identifying a mechanistic relationship between
RBC quality and adverse cardiac end points has
been hindered in the clinical setting by confounding
factors, including disease diagnosis, age, rate/site of
infusion, volume of transfusion per unit time, number
of transfusions, bypass and cross-clamp time, secondary complications from surgery, and concomitant medication administration. Recent randomized
clinical trials have demonstrated that transfusion
with fresh blood (1–10 days storage duration) does
not decrease the risk of mortality compared with
standard practice (2–3 weeks storage duration).44–48
However, considerably less is known about the risk
of transfusing RBCs near expiration (35–42 days), or
the impact on secondary end points including cardiac complications.35,49–51
We aimed to address clinical concerns of bradycardia and cardiac arrest by investigating the direct relationship between RBC storage age and
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myocardial function using experimental models. We
hypothesized that electrical conduction would be impaired in cardiac models exposed to the supernatant of “old” RBC (sRBC) units close to expiration as
compared with “fresh” units, in part because of elevated extracellular potassium that can alter the myocardial resting membrane potential.22,52–54 To test
this hypothesis, electrophysiology parameters were
measured using both an intact, isolated rat heart
preparation and human induced pluripotent stem
cell–derived cardiomyocytes (hiPSC-CM). Cardiac
end points were measured at baseline, and again
after exposure to sRBC collected from “fresh” (day 7
postdonor collection), “old” (day 30–40), or “expired”
units (day 50). We compared these results with those
observed with hyperkalemia, a primary biomarker of
RBC storage lesion severity.29,30,36

METHODS
Data that support the findings of this study are available from the corresponding author upon reasonable request. Animal protocols were approved by the
Institutional Animal Care and Use Committee of the
Children’s National Research Institute, and followed
the National Institutes of Health’s Guide for the Care
and Use of Laboratory Animals.
Downloaded from http://ahajournals.org by on August 6, 2021

RBC Sample Preparation
RBC units (300±50 mL) from healthy donors were
obtained from the American Red Cross or Children’s
National Blood Donor Center. All units were type O
blood, sickle-negative, nonirradiated, collected using
standard single-donor needle methods, and stored in
additive preservative solution (AS-1 or AS-3) according to standards of the American Academy Blood
Banking requirements and the US Food and Drug
Administration.55 Single RBC units were stored at 4
to 6°C in a research-grade, temperature-monitored

refrigerator according to standards.55 RBC units underwent gentle centrifugation (4°C, 20 minutes, 2000g;
Haemonetics) using accumulated centrifugal effect
value of 6.5 × 107 to separate and collect the supernatant (sRBC) 7 to 50 days postdonor collection; sRBC
samples were used for subsequent experiments.
Experiments were designed to study the impact of
RBC storage lesion on cardiac electrophysiology, by
comparing end points after exposure to “fresh” sRBC
(7 days postdonor collection), “old” sRBC (30–40 days),
or “expired” sRBC (50 days).
General Protocol and Biochemical Analysis
Trauma patients and patients undergoing cardiac
surgery or extracorporeal membrane oxygenation
can receive large transfusion volumes ≥60% of the
patient’s total blood volume.56,57 As examples, an estimated 3% to 8% of civilian trauma patients and 10%
of military trauma patients receive large-volume RBC
transfusions,58,59 while >90% of children undergoing cardiopulmonary bypass receive packed RBCs
(average 3.4 RBC units for complex procedures).60
To mimic exposure, we estimated 10% supernatant volume exposure from reconstituted blood (½
volume packed RBCs [20–30% supernatant containing anticoagulant and 70–80% RBCs] and ½
volume plasma). Accordingly, sRBC samples were
diluted to 10% volume using Krebs-Henseleit (KH)
buffered media (denoted in mM: 118 NaCl, 3.29 KCl,
1.2 MgSO4, 1.12 KH2PO4, 24 NaHCO3, 10 glucose, 2
C3H3NaO3, 10 HEPES, and 0.33 CaCl). Biochemical
analyses were performed on each diluted sRBC
sample, using an Epoc® point-of-care blood analysis system (Siemens Diagnostics: SMNS10736382)
to measure Na+, K+, Ca 2+, Cl−, and lactate levels. pH
measurements were performed using an Oakton
700 pH meter, and osmolarity was assessed using
an Advanced Instruments 3300 micro-osmometer
(Table 1).

Table 1. Biochemical Analyses of sRBC Diluted to 10% Volume in KH-Buffered Media
Days of Storage
Parameter (mmol/L)

KH Media

7

30–35

40

50

pH
Osmolarity, mOsm/L

7.38±0.01

7.40±0.01

7.41±0.01

7.40±0.003

7.41±0.01

315±0.58

314±2.65*

315±0.86

318±1.86

K+

319±1.67

4.48±0.04

5.82±0.16*

9.28±0.41*,**

9.28±0.33*,**

9.65±0.26*,**

0.30±0.002

0.79±0.96

2.76±0.24*,**

2.42±0.17*,**

2.98±0.20*,**

−

117.9±0.51

117.9±0.23

117.6±0.32

116.7±0.61

119.3±0.33

Ca 2+

1.70±0.05

1.14±0.11*

0.97±0.10*

1.10±0.13*

1.27±0.11*

Na+

151±0.32

149±0.34*

145±0.45*,**

145±0.80*,**

147±0.33*,**

Lactate
Cl

Storage age was associated with deviations in the electrolyte composition of sRBC samples. Mean±SEM. KH indicates Krebs-Henseleit media; and sRBC,
supernatant from red blood cell units.
*Value differs significantly from control KH buffer, or **Value differs from day 7 sample (P<0.05). n=3–10 per group.
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Intact, Whole Heart Preparations
Experiments were conducted using adult, female
Sprague-Dawley rats (>8 weeks old, >200 g, Taconic
Biosciences). Animals were housed in conventional rat
cages in the Research Animal Facility under standard
environmental conditions (12:12 hour light:dark cycle,
64–78°F, 30–70% humidity, free access to reverse
osmosis water, corncob bedding, and food [2918 rodent chow, Envigo]). Animals were anesthetized with
3% to 5% isoflurane; the heart was then excised and
transferred to a temperature-controlled (37°C), constant-pressure (70 mm Hg) Langendorff-perfusion
system for electrophysiology experiments (Figure 1).
After isolating and transferring the heart to the perfusion system, excised hearts were perfused with KrebsHenseleit buffer bubbled with carbogen (95% oxygen,
5% CO2) throughout the duration of the experiment.61
Pseudo-ECGs were continuously recorded in lead II
configuration during sinus rhythm; ECG signals were
analyzed to quantitate heart rate, atrioventricular conduction (PR interval), ventricular depolarization time
(QRS width), ventricular repolarization (QTc),62 and arrhythmia incidence.63–65 Biosignals were acquired in
iox2 and ECG parameters were analyzed in ecgAUTO
(emka Technologies).
Electrophysiology Measurements
Downloaded from http://ahajournals.org by on August 6, 2021

To further investigate cardiac electrophysiology, a pacing protocol was implemented using stimulation electrodes positioned on the right atrium and the apex of
the left ventricle (Figure 1).63,65 A Bloom Classic electrophysiology stimulator (Fisher Medical) was set at
a pacing current 1.5× the minimum pacing threshold

Figure 1. Heart preparation and experimental timeline
A, Isolated, intact rodent heart with retrograde Langendorffperfusion via an aortic cannula. Pacing electrodes were attached
to the RA and apex of the LV to perform an EP. B, Experimental
timeline included 30-minutes perfusion with KH media,
containing 4.5 mM K+ (control), which commenced with an EP
protocol. Thereafter, the media remained unchanged (control),
supplemented with 10% sRBC, or supplemented with increasing
potassium concentrations. The EP study was repeated
again after 15–20 minutes, and results were compared with
baseline. Timeline created using biorender.com. EP indicates
electrophysiology study; KH, Krebs-Henseleit media; LV, left
ventricle; RA, right atria; and sRBC, supernatant from red blood
cell units.

Storage Lesion and Cardiac Electrophysiology

(1–2 mA) with 1-ms monophasic pulse width. Sinus
node recovery time (SNRT) was assessed by applying a pacing train of 150 ms (S1−S1) to the right atrium
and measuring the time delay until the next spontaneous sinoatrial node–mediated activity. To determine
the Wenckebach cycle length (WBCL), an S1–S1 pacing interval was applied to the right atrium; the pacing
cycle length was decremented stepwise to pinpoint
the shortest interval that resulted in 1:1 atrioventricular conduction. Next, an S1–S2 pacing interval was
applied to the right atrium to determine the atrioventricular nodal effective refractory period (AVNERP). An
S1–S2 pacing interval was applied to the left ventricle
to find the shortest coupling interval that resulted in 1:1
ventricular depolarization, signifying the ventricular effective refractory period (VERP).
Experimental Timeline and Treatment Groups
Isolated, intact hearts were perfused with KH media for
30 minutes, followed by implementation of electrophysiology pacing protocols (“baseline”). Hearts were then perfused for another 15 to 20 minutes, with either KH media
alone (control), media supplemented with 10% sRBC
(7–50 days postdonor collection), or media supplemented
with elevated potassium concentrations (6–12 mM KCl).
Electrophysiology protocols were performed a second
time to determine the effects of sRBC treatment or hyperkalemia on electrical conduction (Figure 1). This protocol
allowed each animal to serve as its own control, and account for experimental or animal variability.
hiPSC-CM Preparation and Microelectrode
Array Recordings
hiPSC-CM (iCell, Cellular Dynamics International) are
commonly used as a model to detect drug-induced
changes in cardiac electrophysiology, including use
in the comprehensive in vitro proarrhythmia assay initiative.66,67 This cell line contains a mixed population
of cardiomyocytes with nodal, atrial, and ventricularlike electrophysiological properties that resemble native cardiomyocytes.68 hiPSC-CM were plated onto
fibronectin-coated microelectrode arrays (MEA 24,
Axion Biosystems), at a density of 30 000 cells per
well. hiPSC-CM were maintained under standard
cell culture conditions (37ºC, 5% CO2). hiPSC-CM
formed a confluent contracting monolayer (40–60
beats per minute) and MEA recordings were performed 7 to 10 days after plating to measure the
spontaneous beating rate. hiPSC-CM were equilibrated in the MEA system for 15 minutes, and then
the spontaneous beating rate was recorded (“baseline”) using an integrated MEA system (Maestro Edge,
Axion Biosystems) with temperature and gas control
(37ºC, 5% CO2). Cardiomyocytes were then treated
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for 5 minutes with iCell maintenance media (control),
media supplemented with 10% sRBC (7 to 40 days
postdonor collection), or media supplemented with
elevated potassium concentrations (9–12 mM).
Spontaneous beating rate was also recorded 1 hour
posttreatment and after washout. To account for cell
plating variability, each treated cardiomyocyte monolayer was compared to baseline.69
Statistical Analysis
Results are reported as mean±SEM. Data normality was
assessed by Shapiro-Wilk testing (GraphPad Prism). For
sRBC measurements, end points were measured before and after treatment within the same heart (baseline
versus treatment) and statistical analysis was performed
using either a 2-tailed paired t test (passed normality
test) or Wilcoxon matched-pairs signed rank test (failed
normality test). For hyperkalemia studies with multiple
doses, statistical analysis was performed using either
1-way ANOVA (passed normality test) or Kruskal-Wallis
nonparametric test (failed normality test), with a false
discovery rate (0.1) to correct for multiple comparisons.
Significance was defined by *P<0.05.

RESULTS
Downloaded from http://ahajournals.org by on August 6, 2021

Storage Age Affects the Biochemical
Composition of sRBC
The attributes of a stored blood product shifts as RBC
quality declines, which can result in an accumulation
of potassium in the supernatant.29,30,36 To measure
the effect of storage time on the electrolyte composition of blood units, sRBC samples were collected
from RBC units on day 7 to 50 postdonor collection,
samples were diluted to 10% volume using pH-buffered KH media, and then electrolyte-gas measurements were performed on the diluted end product
(Table 1). Extracellular potassium levels were elevated
in “old” units as compared with “fresh” units (day 7:
5.8±0.2 versus day 40: 9.3±0.3 mM, P<0.0001); but
there was variability between age-matched units near
expiration ranging from 7.5 to 11.9 mM [K+] in the 10%
diluted end product (day 30–50). Lactate levels were
elevated in older blood units (day 7: 0.8±1 versus day
40: 2.4±0.2 mM, P <0.0001), and sodium concentration declined slightly with storage age (day 7: 149±0.3
versus day 40: 145±0.8 mM, P <0.0001). pH and osmolarity values were similar between preparations.

Storage Age Is Associated With Heart
Rate Slowing and Sinus Node Dysfunction
Cardiac complications from RBC transfusion include an increased risk of bradycardia and cardiac

Figure 2. RBC storage age is associated with heart rate
slowing and sinus node dysfunction
A, Biosignals recorded from isolated hearts perfused with media
supplemented with 10% sRBC collected from a day 7 unit, or
(B) day 40 unit. ECGs were recorded during sinus rhythm (RR
interval highlighted), followed by train of atrial paces (black
arrowheads denote pacing spikes). Each atrial pace results
in a ventricular response. SNRT was measured from the last
pacing spike to resumption of sinus rhythm. C, Stable heart rate
following exposure to RBC units aged 7–30 d, but bradycardia
observed with sRBC collected from units aged ≥ 40 d. D, HR
slowing observed at highest potassium concentration tested
(12 mM K+). E, Exposure to day 40 sRBC resulted in slowed sinus
node recovery, or complete cessation of sinus function with day
50 sRBC. F, Increased SNRT also observed at highest potassium
concentration tested (12 mM K+). Mean±SEM, *P<0.05, n=3–6.
BPM indicates beats per minute; HR, heart rate; RBC, red blood
cell; SNRT, sinus node recovery time; and sRBC, supernatant
from red blood cell units.

arrest.14,15,18,21 These adverse outcomes may be precipitated by elevated extracellular potassium, which
diminishes the myocardial resting membrane potential.53,54 Accordingly, we assessed the impact of
sRBC exposure on spontaneous heart rate and sinus
node function in Langendorff-perfused hearts. Heart
rate remained stable throughout the study when
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Figure 3. RBC storage age is associated with slowed atrioventricular conduction
A, Pseudo-ECGs recorded during sinus rhythm from isolated hearts perfused with control media (left), media supplemented with 10%
sRBC collected from a day 7 unit (middle) or day 40 unit (right). PR interval time is denoted. (B,C) Atrioventricular conduction slows
in the presence of day 40 and day 50 sRBC, or 10–12 mM K+. (D,E) Exposure to sRBC units had no measurable effect on ventricular
depolarization time (QRS) during sinus rhythm. Mean±SEM, *P<0.05, n=3–6. RBC indicates red blood cell; and sRBC, supernatant
from red blood cell units.

perfused with control media containing 4.5 mM K+
(baseline: 297±10 versus 45 minutes: 288±15 beats
per minute), and also remained stable when the perfusate was supplemented with 10% sRBC collected

from RBC units aged 7 to 30 days (Figure 2).
Similarly, sinus node function remained stable with
control media perfusion (SNRT baseline: 223±14 versus 45 minutes: 238±9) and following perfusion with
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Figure 4. RBC storage age is associated with increased refractoriness of the AV node
A, Biosignals recorded with atrial pacing (S1-S1) to measure WBCL in isolated hearts in the presence of day 7 sRBC,
(B) day 40 sRBC, or (C) 10 mM K+. D, Slowed AV node conduction following exposure to sRBC from older units, but
not “fresh” day 7 units. E, Slowed AV conduction following exposure to 10–12 mM K+. Arrowheads denote ventricular
response to atrial pacing at S1 (black) pacing cycle length. ≠ denotes failed conduction. Mean±SEM, *P<0.05, n≥3. AV
indicates atrioventricular; sRBC, supernatant from red blood cell units; and WBCL, Wenckebach cycle length.
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Figure 5. RBC storage age is associated with an increased AV node effective refractory period
A, Biosignals recorded with atrial pacing (S1–S2) to pinpoint AVNERP in the presence of day 7 sRBC, (B) day 40 sRBC, or
(C) 10 mM K+. D, AVNERP did not change after exposure to day 7–30 sRBC, but increased with day 40 and day 50 sRBC
exposure. E, AVNERP increased with severe hyperkalemia. Arrowheads denote ventricular response to atrial pacing at
S1 (black) or S2 (gray) pacing cycle length. ≠ denotes failed conduction. Mean±SEM, *P<0.05, n=3–6. AVNERP indicates
atrioventricular node effective refractory period; RBC, red blood cell; sRBC, supernatant from red blood cell units.
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10% sRBC collected from units aged 7 to 30 days
(Figure 2). However, as RBC units neared expiration,
sRBC exposure slowed the heart rate by 23% (baseline: 279±5 versus day 40: 216±18 beats per minute,
P<0.005). Additionally, sRBC from day 40 units had
a significant effect on sinus node function, delaying
the recovery time by 46% (SNRT baseline: 243±8 ms
versus day 40: 354±23 ms, P<0.005). In the latter,
the perfusate media had a mean potassium concentration >9 mM (Table 1). To measure the direct effect
of hyperkalemia on automaticity and sinus function,
a dose–response study was performed. As the potassium concentration increased from 4.5 to 12 mM,
heart rate slowed (linear regression R2 = 0.92, P=0.01)
and SNRT was prolonged (R2 = 0.86, P=0.02).

Storage Age Is Associated With
Atrioventricular Conduction Slowing

Downloaded from http://ahajournals.org by on August 6, 2021

Electrochemical gradients across the cardiomyocyte membrane are essential for cardiac excitation
and electrical propagation. Atrial cardiomyocytes are
particularly sensitive to deviations in these electrochemical gradients, and an increase in extracellular
potassium can slow atrioventricular conduction.32,53,70
Atrioventricular conduction remained constant in
hearts perfused with control KH media throughout the
study (Figure 3), as determined by ECG parameters
during sinus rhythm (PR time at baseline: 33±4 versus 45 minutes: 36±2). Similar results were observed
before and after exposure to 10% sRBC samples collected from units aged 7 to 30 days, but significant
slowing was observed after exposure to sRBC near or
after expiration (PR time at baseline: 33±1 versus day
40: 41±3 ms, P<0.05; PR time at baseline: 37±1 versus day 50: 53±8 ms, P<0.005). Atrioventricular node
refractoriness was further interrogated by implementing an atrial pacing protocol to measure WBCL (S1-S1
pacing) and AVNERP (S1-S2 pacing). These parameters remained unchanged in hearts perfused with control media (WBCL baseline: 79±2 versus 45 min: 83±2;
AVNERP baseline: 64±5 versus 45 minutes: 67±4)
and hearts exposed to sRBC from “fresh” 7-day units
(Figures 4 and 5). Exposure to day 30 sRBC resulted in
a modest increase in AV node refractoriness, increasing WBCL by 9%. Effects on the AV node were more
pronounced after exposure to day 40 sRBC, which increased AVNERP by 21% (baseline: 77±2 versus day
40: 93±7 ms, P=0.01) and WBCL by 19% (baseline:
90±1 versus day 40: 107±3 ms, P<0.001). A 66% increase in AVNERP was observed in units stored past
expiration (baseline versus day 50 sRBC; Figure 5).
As anticipated, a dose–response relationship was
observed when the potassium concentration was
increased in the perfusate media, resulting in prolonged atrioventricular conduction time and increased
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atrioventricular node refractoriness. As the potassium
concentration increased from 4.5 to 12 mM, a progressive increase in PR duration (R2 = 0.85, P<0.05)
was observed (Figure 3). At 10 mM K+ (a concentration
comparable to day 40 sRBC-supplemented media), a
51% increase in WBCL was observed (4.5 mM: 84±3 to
10 mM: 127±13 ms, P<0.005), but changes in AVNERP
were only observed at 12 mM K+ (4.5 mM: 71±3 to
12 mM: 151±21 ms, P<0.005; Figures 4 and 5). The latter suggests that other factors or substances in the RBC
supernatant may also contribute to conduction slowing.

Storage Age Increases Ventricular
Refractoriness
Severe hyperkalemia is associated with decreased sodium channel availability and slowed conduction velocity, which results in QRS widening and may precipitate
ventricular tachyarrhythmias.32,53,70 In our model, exposure to sRBC-supplemented media did not significantly alter the QRS duration (baseline: 26±2 ms
versus day 40: 34±9 ms; Figure 3), QTc duration (baseline: 169±9 versus day 40: 172±11 ms), or increase the
incidence of ventricular tachyarrhythmias (data not
shown). Furthermore, we were not able to establish a
linear trend toward QRS prolongation with increasing
potassium concentration (R2 = 0.72, P=0.07), QTc duration (R2 = 0.67, P=0.67) or an increased incidence of
ventricular tachyarrhythmias, which may be attributed
to limitations in our model system. Indeed, ventricular activation and early repolarization can occur simultaneously in the rodent heart, which can influence
the QRS complex and result in indistinct T-waves.71
Moreover, the rodent myocardium is less than ideal for
assessing arrhythmia incidence because of its small
size and resilience to fibrillation.71 As another indicator of ventricular repolarization time, we implemented a
pacing protocol to pinpoint ventricular refractoriness. A
marginal increase in extracellular potassium can hasten repolarization and shorten action potential duration
time, but severe hyperkalemia increases postrepolarization refractoriness.54,72,73 As expected, control media
perfusion resulted in stable VERP measurements
throughout the study (VERP baseline: 45±5 versus
45 minutes: 46±2 ms). VERP measurements were unchanged in heart preparations exposed to sRBC from
day 7 to 30 RBC units (Figure 6), but VERP increased
by 96% following exposure to day 40 sRBC (baseline: 50±3 versus day 40: 98±10 ms, P<0.0001) and
145% after exposure to expired units (baseline: 51±8
versus day 50: 126±25 ms, P<0.0001). This increase
in ventricular refractoriness may be explained, at least
partly, by the increase in extracellular potassium levels.
In dose–response studies, increasing potassium concentration (4.5–12 mM) also resulted in a progressive
increase in VERP (linear regression, R2 = 0.91, P=0.01).
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Figure 6. RBC storage age is associated with increased ventricular refractoriness
A, Biosignals recorded with ventricular pacing (S1–S2) to pinpoint the VERP in isolated hearts perfused with media supplemented
with 10% sRBC collected from a day 7 unit, (B) day 40 unit, or (C) 10 mM K+. D, Ventricular refractoriness was unchanged after
exposure to day 7–30, but increased with day 40–50 sRBC and (E) media supplemented with 8–12 mM K+. Arrowheads denote
ventricular response to pacing at S1 (black) or S2 (gray) pacing cycle length. ≠ denotes failed conduction. Mean±SD, *P<0.05,
n=3–6. RBC indicates red blood cell; sRBC, supernatant from red blood cell units; and VERP, ventricular effective refractory period.
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hiPSC-CM Are Susceptible to Electrical
Disturbances
Rodent models are frequently employed in cardiovascular research studies, although species-specific
differences in ion channel expression are established.74,75 Accordingly, we performed a follow-up
study using hiPSC-CM to validate the effects of
sRBC exposure. Using a MEA system, we noted an
increase in the beating rate of hiPSC-CM over time
when treated with day 7 sRBC (5 minutes: 12±6% rate
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increase P=0.09 versus 60 minutes: 33±5% P<0.005,
Figure 7). Conversely, cardiomyocytes demonstrated
bradycardia after exposure to “older” sRBC products,
which was more severe than reported in the whole
heart experiments. The spontaneous beating rate of
hiPSC-CM decreased by 47±7% in day 35 samples
and 75±9% in day 40 samples relative to baseline
measurements (P<0.0001). Significant slowing in the
spontaneous beating rate was also observed with
increasing potassium concentrations (4.5–12 mM K+;

Downloaded from http://ahajournals.org by on August 6, 2021
Figure 7. Reduced automaticity in hiPSC-CM
A, Microelectrode array heat map shows 16-electrode recordings from hiPSC-CM treated with control media (4.5 mM K+), media
with increasing potassium concentrations (9–12 mM K+), or 10% sRBC collected from RBC units aged 7–40 days. The heat map
corresponds to the spontaneous beating rate. B, Biosignals recorded from hiPSC-CM show a decline in beating rate with elevated
potassium concentrations. C, Percent change in beating rate following treatment with elevated potassium concentrations, compared
with baseline. D, Biosignals show a decline in the beating rate with “older” sRBC samples (day 35–40) but not “fresh” sRBC samples (day
7). E, Percent change in beating rate following sRBC treatment, compared with baseline. Mean±SEM, n=12–24, *Significantly different
from baseline, P<0.05. BPM indicates beats per minute; hiPSC-CM, human induced pluripotent stem cell–derived cardiomyocytes;
RBC, red blood cell; and sRBC, supernatant from red blood cell units.
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R2 = 0.999, P=0.01). Notably, treatment did not appear to have a lasting effect on cardiomyocyte viability, as the beating rate quickly returned to normal
after washing out the sRBC or hyperkalemic media
(Figure 7).

DISCUSSION
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Clinical case reports have documented transfusionassociated hyperkalemia, which can lead to conduction disturbances, ventricular tachycardias, and/
or cardiac arrest.14,15,18,19,22,32,52 Furthermore, studies
suggest that transfusion-associated adverse events
may be associated with the storage age of blood
products, as RBCs undergo a cascade of morphological, biochemical, and metabolic changes over
time that are collectively termed the “RBC storage
lesion” or “metabolic aging.”14,18,19,76 This study is the
first to demonstrate that “older” blood products may
directly impact myocardial automaticity and electrical conduction, using experimental cardiac models.
Importantly, we show that supernatant collected from
“fresh” RBC units (7 days postdonor collection) had
no effect on heart rate, sinus node function, atrial or
atrioventricular conduction, or myocardial refractoriness in an isolated, whole heart model. A follow-up
study in hiPSC-CM revealed that supplementation
with 10% sRBC from “fresh” units (day 7) caused
a modest increase in the spontaneous beating rate
over time, which may be attributed to mild hyperkalemia (5.8±0.2 mM K+). In comparison, whole heart
preparations exposed to supernatant from aged
RBC units (>30 days postcollection) displayed bradycardia, slowed atrial and atrioventricular conduction,
and an increase in the refractoriness of the ventricle
and AV node. Notably, other groups have suggested
that the maximal allowable RBC storage duration be
reduced from 42 to 35 days, because of increased
hemolysis and a sharp increase in nontransferrinbound iron after 5 weeks in refrigerated storage.24
Although we did not measure either free iron or nontransferrin-bound iron levels in this study, our results
closely align with this conclusion, as electrophysiological disturbances were predominately observed
in units stored 30+ days postdonor collection.

Mechanistic Links Between RBC
Transfusion and Adverse Cardiac
Outcomes
Blood transfusion complications include an increased
risk of bradycardia and cardiac arrest, which may be
precipitated by an elevated potassium level in the
supernatant of RBC units.14,15,21,22,52 As extracellular
potassium increases, electrochemical gradients are
diminished and the cardiomyocyte resting membrane

Storage Lesion and Cardiac Electrophysiology

potential becomes less negative.54,70,72 Accordingly,
mild hyperkalemia can enhance cardiomyocyte excitability, similar to our observation with day 7 sRBC
treatment in hiPSC-CM. However, with more severe
hyperkalemia, the change in resting membrane potential decreases the availability of voltage-gated
sodium channels that are critical to depolarization
and myocardial excitability.54 Accordingly, severe hyperkalemia is marked by sinus node dysfunction and
sinus arrest.53 Similar observations were observed in
our study when cardiac preparations were exposed
to increasing potassium concentrations, a prominent
biomarker of RBC storage lesion that can, at least
in part, contribute to the electrical disturbances observed in this study.
As described above, hyperkalemia shifts the resting membrane potential and reduces the availability of
voltage-gated sodium channels. As the action potential upstroke slows, electrical conduction slows, which
manifests as a prolongation of P-waves, PR interval,
and QRS interval time.54,70,72 Atrial cardiomyocytes are
the most sensitive to elevated potassium concentrations, followed by the ventricular myocardium and then
specialized conductive tissue, including the sinoatrial
node and bundle of His.54,70,72 Accordingly, electrical
disturbances attributed to high [K+] are initially observed as widened p-waves with shorter amplitudes,
followed by atrioventricular and ventricular conduction delays as extracellular [K+] continues to increase.
Instead of a gradual change in cardiac parameters, we
observed a global depression in electrical conduction
that was largely limited to sRBC samples near expiration and/or 10 to 12 mM K+ perfusion. The latter may
be attributed to the sensitivity of our model system,71
species-specific differences in ion channel expression and electrophysiology,74,75 and/or other attributes
of the RBC storage lesion (eg, lactate, free-iron, and
plasticizer leaching) that may have additional effects on
cardiac electrophysiology.24,25,27,63,77
Although not investigated in the present study,
phthalate chemical exposure is another potential
contributor to heart rate slowing and sinus node dysfunction. Phthalate chemicals are frequently used as
plasticizers in blood bags, and studies have shown
that storage age is associated with an accumulation
of harmful phthalate chemicals in the supernatant of
stored RBC products (18-fold increase, day 5 versus
42 postdonor collection).77 Phthalate chemical exposure has been associated with bradycardia in vivo,78 in
vitro,79 and using an isolated heart model.80 Moreover,
our laboratory previously reported that phthalate plasticizers can lead to sinus node dysfunction in an isolated
heart model, delaying SNRT by 54% compared with
control.63 Additional studies are needed to investigate
the additive effects that may result from hyperkalemia
and phthalate chemical exposure.
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Clinical Implications
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In the current study, we focused our attention on hyperkalemia as 1 potential mechanism for the electrophysiology disturbances observed in our model system
after exposure to “old” RBC samples. Hyperkalemia
has been reported in >70% of adult trauma patients
following transfusion,18 and observed in 18% to 23%
of pediatric trauma patients following transfusion.33
Moreover, Smith et al. reported that an increase in
serum potassium levels (5.9–9.2 mEq/L) was associated with a higher risk of cardiac arrest,15 which is more
likely to occur following rapid transfusion, large-volume
transfusion, or in cases of low cardiac output that
impairs the redistribution of potassium.14,19 Potential
solutions to help mitigate the risk of hyperkalemia include prebypass filtering,81 washing RBCs,21 or limiting
RBC storage duration.14,15,18,20,24 Notably, longer blood
storage duration has been associated with suboptimal outcomes in high-risk pediatric surgery cases12
and cardiac operations.17,20 Recent randomized controlled trials have indicated that transfusion of “fresh”
blood (eg, 1–10 days) does not decrease the risk of
mortality when compared with standard of care (eg,
2–3 weeks).44-48 However, much less is known about
the safety of prolonged RBC storage (eg, 30–42 days)
or the impact of “old” blood products on secondary
cardiac end points.35,49 Accordingly, expert panels
have highlighted the lack of evidence-based data to
reach consensus on the safety of RBC storage age
in relation to critically ill children, including those undergoing surgical repair for congenital heart defects
or those undergoing extracorporeal membrane oxygenation.82,83 The presented study highlights the importance of studying the direct impact of RBC storage
lesion on end-organ function, with an emphasis on
cardiac electrophysiology given the sensitivity of the
heart to electrolyte disturbances.

LIMITATIONS
The scope of our study was limited to the effects of
acute cardiac exposure to supernatant collected from
RBC units. Whole heart and cardiomyocyte models
were used to investigate the direct effects of sRBCmediated biochemical disturbances on electrical activity. Although hiPSC-CM are frequently employed
in preclinical testing, it is important to note that these
cells can display a less mature phenotype compared
with adult cardiomyocytes.84 Moreover, in vitro and ex
vivo results may differ from those observed in vivo, with
an intact vascular and autonomic nervous system. To
mimic patient exposure following a large transfusion,
we estimated 10% supernatant volume exposure from
reconstituted blood, based on volumes reported in
trauma cases, cardiac surgery, and/or extracorporeal
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membrane oxygenation studies. Additional studies are
warranted to assess additional effects that may result
from reconstituted blood containing aged RBCs, or
the risk to sensitive populations including those with
low cardiac output. Further studies are warranted to
investigate alternative mechanisms that may contribute to cardiovascular dysfunction, including additional
biochemical and metabolic alterations in stored RBC
units.26,36,77
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